Your session is about to expire
← Back to Search
Other
Acupuncture for Sickle Cell Disease Pain Management
N/A
Recruiting
Research Sponsored by Indiana University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Age range: 14-17 (Adolescents) and 18-80 (Adults)
Diagnosed with SCD (includes but not limited to SS, SC or other type) and experiencing chronic pain in the past 6 months or vaso-occlusive crisis (VOC) in the past 12 months
Must not have
Significant visual, motor, or auditory impairment that would interfere with ability to perform study visits-related activities
Presence of a concurrent autoimmune or inflammatory disease that causes pain or any other chronic pain condition with pain greater than sickle pain
Timeline
Screening 3 weeks
Treatment Varies
Follow Up changes of pain-related quality of life scores from baseline to post-treatment time point (approximately 5 weeks interval), as well as monthly follow-up visits till the 12th month of last in-person visit.
Awards & highlights
No Placebo-Only Group
Summary
This trial will test if acupuncture can help relieve pain for patients with sickle cell disease, and if so, try to understand how it works.
Who is the study for?
This trial is for right-handed individuals aged 14-80 with sickle cell disease (SCD), experiencing chronic pain or vaso-occlusive crises. Participants must be fluent in English, able to travel for study visits, and willing to limit new pain treatments during the trial. Pregnant/nursing individuals, those with coagulation issues, recent acupuncture treatment, certain chronic conditions or severe psychiatric illnesses are excluded.
What is being tested?
The study tests the effectiveness of acupuncture as a pain management method in SCD patients against a sham procedure (placebo). It involves scheduled visits for questionnaires and various tests like MRI and EEG over five weeks with up to two acupuncture sessions weekly.
What are the potential side effects?
While not specified here, common side effects of acupuncture may include soreness, minor bleeding or bruising at needle sites. The risk of serious side effects is low but could involve injury if needles touch organs.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
I am between 14 and 80 years old.
Select...
I have sickle cell disease and have had chronic pain or a pain crisis in the last year.
Exclusion Criteria
You may be eligible for the trial if you check “No” for criteria below:Select...
I do not have severe vision, hearing, or movement problems affecting study activities.
Select...
I have a chronic pain condition more severe than my sickle cell pain.
Select...
I have a blood clotting issue that may make acupuncture unsafe for me.
Select...
I am suspected of or confirmed to have Covid-19.
Select...
I have nerve damage that affects my daily activities.
Select...
I have had vascular surgery on my legs or currently have leg circulation problems.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ changes of pain-related quality of life scores from baseline to post-treatment time point (approximately 5 weeks interval), as well as monthly follow-up visits till the 12th month of last in-person visit.
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~changes of pain-related quality of life scores from baseline to post-treatment time point (approximately 5 weeks interval), as well as monthly follow-up visits till the 12th month of last in-person visit.
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Functional brain connectivity characteristics
Somatosensory function
Secondary study objectives
Adult Sickle Cell Quality Measure (ASCQ-ME) Questionnaire
Brain metabolites characteristics
Brief Pain Inventory (BPI) Questionnaire
+8 moreOther study objectives
Blood hemoglobin level
Brain hemodynamic activity
Brain structural characteristics
+5 moreAwards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
2Treatment groups
Experimental Treatment
Group I: Needling AcupunctureExperimental Treatment1 Intervention
Group II: Laser AcupunctureExperimental Treatment1 Intervention
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
laser acupuncture
2013
Completed Phase 3
~90
Find a Location
Who is running the clinical trial?
National Center for Complementary and Integrative Health (NCCIH)NIH
859 Previous Clinical Trials
672,250 Total Patients Enrolled
Indiana UniversityLead Sponsor
1,039 Previous Clinical Trials
1,218,938 Total Patients Enrolled
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I can be treated as an outpatient or inpatient.I have not started or changed the dose of stimulant medications in the last 30 days.I do not have severe vision, hearing, or movement problems affecting study activities.I can visit the study site regularly for 5 weeks to receive acupuncture.I am taking pain medication or treatments for my condition as prescribed by my doctor.My gender does not affect my eligibility.I am between 14 and 80 years old.I have a chronic pain condition more severe than my sickle cell pain.I have a blood clotting issue that may make acupuncture unsafe for me.I am suspected of or confirmed to have Covid-19.I have used acupuncture for pain management in the last 6 months.I have nerve damage that affects my daily activities.I don't have metal implants or conditions that make MRI scans unsafe for me.I have had vascular surgery on my legs or currently have leg circulation problems.I am willing to limit my pain medications during the study.I am not currently hospitalized or experiencing a VOC.I have sickle cell disease and have had chronic pain or a pain crisis in the last year.
Research Study Groups:
This trial has the following groups:- Group 1: Needling Acupuncture
- Group 2: Laser Acupuncture
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Share this study with friends
Copy Link
Messenger